Wilhelmus Groenhuysen

COO

CFO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

NVCR

Current role

COO, CFO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	NovoCure Ltd (NVCR)	Chief Operating Officer	$615,000	$0	$3,333,263	$1,668,842	$328,410	$22,150	$5,967,665
2022	NovoCure Ltd (NVCR)	Chief Operating Officer	$615,000	$0	$3,533,227	$2,084,406	$369,000	$22,649	$6,624,282
2021	NovoCure Ltd (NVCR)	Chief Operating Officer	$615,000	$0	$3,833,245	$1,914,408	$0	$24,308	$6,386,961
2020	NovoCure Ltd (NVCR)	Chief Operating Officer	$611,400	$250,000	$3,666,529	$1,827,243	$553,500	$29,252	$6,937,924
2019	NovoCure Ltd (NVCR)	Chief Operating Officer	$600,600	$0	$962,485	$2,202,814	$396,396	$33,789	$4,196,084
2018	NovoCure Ltd (NVCR)	Chief Operating Officer	$600,600	$0	$489,580	$1,966,162	$375,375	$27,500	$3,459,217
2017	NovoCure Ltd (NVCR)	Chief Financial Officer	$600,600	—	$929,500	$1,195,857	$360,360	$30,765	$3,117,082

No earnings-call appearances or filed executive changes recorded yet.